Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

NCT02885324 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT02885324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02885324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
Lead sponsor
Indiana University
Phase
Phase 2
Overall status
Terminated
Start date
May 18, 2017
Completion date
August 25, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, glioblastoma multiforme, high grade glioma, malignant brain tumor